The Zhitong Finance App learned that Ping An Health (01833) rose more than 5% in the intraday period. As of press release, it had risen 4.09% to HK$10.18, with a turnover of HK$307.35,800.
According to the news, Ping An Health announced that after announcing the launch of the online medical insurance drug purchase service in Dongguan at the end of March, online medical insurance payments have now also been implemented in Guangzhou. This time, Guangzhou Medical Insurance also supports co-ordinated accounts and personal accounts to provide users with new payment options, further enhance the convenience of online drug purchases, and reduce the financial burden on citizens. The person in charge of Ping An Health said that in the future, Ping An Health will launch online medical insurance drug purchase services one after another in other cities across the country.
UBS previously released a research report with a target price of HK$20 for Ping An Health. The steady progress of Strategy 2.0 has reduced losses rapidly, and the steady growth of the F-side business is compounded by the rapid growth of the B-side business. Damo, on the other hand, said that considering the further reduction in the company's adjusted net loss and the smooth progress of “front-end+back-end” expansion, the target price for Ping An Health is HK$21. Dahua Jixian expects revenue to grow at a CAGR of 18% in 2023-25 thanks to continuous strategic upgrading efforts.